Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00008736
Recruitment Status : Completed
First Posted : January 18, 2001
Last Update Posted : June 24, 2005
Sponsor:
Collaborator:
Children's Hospital of Philadelphia
Information provided by:
National Center for Research Resources (NCRR)

Brief Summary:
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.

Condition or disease Intervention/treatment Phase
Infant, Newborn, Diseases Drug: metoclopramide Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Primary Purpose: Treatment
Official Title: Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 1 Month   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion:

Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00008736


Locations
Layout table for location information
United States, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
National Center for Research Resources (NCRR)
Children's Hospital of Philadelphia

Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00008736     History of Changes
Other Study ID Numbers: NCRR-M01RR00240-1724
First Posted: January 18, 2001    Key Record Dates
Last Update Posted: June 24, 2005
Last Verified: December 2003

Keywords provided by National Center for Research Resources (NCRR):
Feeding intolerance
Infant, premature

Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Infant, Newborn, Diseases
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Metoclopramide
Antiemetics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Dopamine D2 Receptor Antagonists
Dopamine Antagonists
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action